Go Pro

KBC Group NV Sells 65,545 Shares of MetLife, Inc. $MET

MetLife logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • KBC Group NV reduced its MetLife stake by 4.6% in the first quarter, selling 65,545 shares and leaving it with 1,355,024 shares valued at about $95.8 million.
  • Several analysts remain bullish on MetLife, with recent target-price increases from JPMorgan, Jefferies, KBW, UBS, and Mizuho. The stock carries a Moderate Buy consensus and an average price target of $98.57.
  • MetLife reported Q1 EPS of $2.42, beating estimates, and announced a quarterly dividend of $0.5925 per share to be paid on September 8, implying a 2.5% yield.
  • MarketBeat previews top five stocks to own in August.

KBC Group NV trimmed its position in shares of MetLife, Inc. (NYSE:MET - Free Report) by 4.6% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,355,024 shares of the financial services provider's stock after selling 65,545 shares during the quarter. KBC Group NV owned 0.21% of MetLife worth $95,828,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently modified their holdings of MET. Activest Wealth Management lifted its holdings in MetLife by 205.8% in the fourth quarter. Activest Wealth Management now owns 315 shares of the financial services provider's stock valued at $25,000 after acquiring an additional 212 shares during the period. Garton & Associates Financial Advisors LLC bought a new stake in shares of MetLife during the 4th quarter valued at about $30,000. Sound Income Strategies LLC increased its position in shares of MetLife by 58.9% during the 4th quarter. Sound Income Strategies LLC now owns 383 shares of the financial services provider's stock valued at $29,000 after purchasing an additional 142 shares during the last quarter. Gunpowder Capital Management LLC dba Oliver Wealth Management bought a new position in shares of MetLife in the 4th quarter worth approximately $31,000. Finally, Prosperity Bancshares Inc purchased a new position in shares of MetLife in the fourth quarter worth approximately $31,000. 94.99% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on MET shares. JPMorgan Chase & Co. boosted their target price on shares of MetLife from $95.00 to $96.00 and gave the company an "overweight" rating in a research report on Tuesday, May 12th. Jefferies Financial Group increased their price target on shares of MetLife from $97.00 to $103.00 and gave the stock a "buy" rating in a research report on Friday, July 10th. Keefe, Bruyette & Woods lifted their price target on shares of MetLife from $98.00 to $105.00 and gave the stock an "outperform" rating in a research note on Monday, July 13th. UBS Group boosted their price objective on shares of MetLife from $102.00 to $105.00 and gave the company a "buy" rating in a research report on Wednesday, July 8th. Finally, Mizuho upped their price objective on MetLife from $95.00 to $102.00 and gave the stock an "outperform" rating in a research note on Thursday, July 9th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, MetLife currently has a consensus rating of "Moderate Buy" and a consensus target price of $98.57.

Get Our Latest Stock Analysis on MET

MetLife Trading Down 0.0%

Shares of NYSE:MET opened at $93.99 on Monday. The stock has a 50 day moving average of $85.80 and a 200 day moving average of $79.07. The company has a market cap of $60.48 billion, a PE ratio of 18.21, a price-to-earnings-growth ratio of 0.72 and a beta of 0.78. MetLife, Inc. has a 12-month low of $67.33 and a 12-month high of $94.86. The company has a current ratio of 0.20, a quick ratio of 0.20 and a debt-to-equity ratio of 0.53.

MetLife (NYSE:MET - Get Free Report) last released its earnings results on Wednesday, May 6th. The financial services provider reported $2.42 EPS for the quarter, topping analysts' consensus estimates of $2.27 by $0.15. MetLife had a net margin of 4.66% and a return on equity of 22.60%. The company had revenue of $14.18 billion for the quarter, compared to analysts' expectations of $19.49 billion. During the same quarter last year, the business earned $1.96 EPS. The firm's revenue was up 2.7% compared to the same quarter last year. As a group, equities research analysts expect that MetLife, Inc. will post 9.94 EPS for the current year.

MetLife Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 8th. Stockholders of record on Tuesday, August 4th will be given a dividend of $0.5925 per share. This represents a $2.37 annualized dividend and a dividend yield of 2.5%. The ex-dividend date is Tuesday, August 4th. MetLife's dividend payout ratio (DPR) is presently 45.93%.

Key MetLife News

Here are the key news stories impacting MetLife this week:

About MetLife

(Free Report)

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.

Recommended Stories

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET - Free Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in MetLife Right Now?

Before you consider MetLife, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.

While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines